1. Home
  2. AMKR vs PRAX Comparison

AMKR vs PRAX Comparison

Compare AMKR & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amkor Technology Inc.

AMKR

Amkor Technology Inc.

HOLD

Current Price

$67.38

Market Cap

11.5B

Sector

Technology

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$342.99

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMKR
PRAX
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5B
9.6B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
AMKR
PRAX
Price
$67.38
$342.99
Analyst Decision
Buy
Strong Buy
Analyst Count
9
15
Target Price
$52.88
$572.13
AVG Volume (30 Days)
3.1M
379.3K
Earning Date
04-27-2026
05-08-2026
Dividend Yield
0.53%
N/A
EPS Growth
4.90
N/A
EPS
1.50
N/A
Revenue
$4,052,650,000.00
N/A
Revenue This Year
$13.24
N/A
Revenue Next Year
$9.90
$6,395.88
P/E Ratio
$41.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.24
$32.78
52 Week High
$64.80
$354.87

Technical Indicators

Market Signals
Indicator
AMKR
PRAX
Relative Strength Index (RSI) 75.97 59.58
Support Level $40.30 $282.49
Resistance Level N/A $354.87
Average True Range (ATR) 3.34 20.14
MACD 1.89 3.55
Stochastic Oscillator 92.73 87.37

Price Performance

Historical Comparison
AMKR
PRAX

About AMKR Amkor Technology Inc.

Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: